Abstract
The Minority Aging Research Study (MARS) is a longitudinal, epidemiologic cohort study of decline in cognitive function and risk of Alzheimer’s disease (AD) in older African Americans, with brain donation after death added as an optional component for those willing to consider organ donation. In this manuscript, we first summarize the study design and methods of MARS. We then provide details of ongoing efforts to achieve neuropathologic data on over 100 African Americans participating in MARS and in three other clinical-pathologic cohort studies at Rush University Medical Center. The results examine strategies for recruiting and consenting African Americans without dementia; 2) efforts to maintain high rates of follow-up participation; 3) strategies for achieving high rates of agreement to brain donation; and 4) the methodology of obtaining rapid brain autopsy at death. The implications of these efforts are discussed.
Keywords: Neuropathology, African American, aging, epidemiologic studies, longitudinal, cognitive impairment, neurofibrillary tangles
Current Alzheimer Research
Title:The Minority Aging Research Study: Ongoing Efforts to Obtain Brain Donation in African Americans without Dementia
Volume: 9 Issue: 6
Author(s): Lisa L. Barnes, Raj C. Shah, Neelum T. Aggarwal, David A. Bennett and Julie A. Schneider
Affiliation:
Keywords: Neuropathology, African American, aging, epidemiologic studies, longitudinal, cognitive impairment, neurofibrillary tangles
Abstract: The Minority Aging Research Study (MARS) is a longitudinal, epidemiologic cohort study of decline in cognitive function and risk of Alzheimer’s disease (AD) in older African Americans, with brain donation after death added as an optional component for those willing to consider organ donation. In this manuscript, we first summarize the study design and methods of MARS. We then provide details of ongoing efforts to achieve neuropathologic data on over 100 African Americans participating in MARS and in three other clinical-pathologic cohort studies at Rush University Medical Center. The results examine strategies for recruiting and consenting African Americans without dementia; 2) efforts to maintain high rates of follow-up participation; 3) strategies for achieving high rates of agreement to brain donation; and 4) the methodology of obtaining rapid brain autopsy at death. The implications of these efforts are discussed.
Export Options
About this article
Cite this article as:
L. Barnes Lisa, C. Shah Raj, T. Aggarwal Neelum, A. Bennett David and A. Schneider Julie, The Minority Aging Research Study: Ongoing Efforts to Obtain Brain Donation in African Americans without Dementia, Current Alzheimer Research 2012; 9 (6) . https://dx.doi.org/10.2174/156720512801322627
DOI https://dx.doi.org/10.2174/156720512801322627 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Microglial Innate Immunity in Alzheimers Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma
Current Medicinal Chemistry Thin, Stubby or Mushroom: Spine Pathology in Alzheimers Disease
Current Alzheimer Research Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies
Current Medical Imaging Uleine Disrupts Key Enzymatic and Non-Enzymatic Biomarkers that Leads to Alzheimer’s Disease
Current Alzheimer Research The Neuroprotective Role of Repetitive Transcranial Magnetic Stimulation (rTMS) for Neurodegenerative Diseases: A Short Review on Experimental Studies
Mini-Reviews in Medicinal Chemistry Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Flow and Microwave Assisted Synthesis of Medicinally Relevant Indoles
Current Green Chemistry Anesthesia, Calcium Homeostasis and Alzheimers Disease
Current Alzheimer Research Relationships Between White Matter Hyperintensities, Cerebral Amyloid Angiopathy and Dementia in a Population-based Sample of the Oldest Old
Current Alzheimer Research Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression
Current Alzheimer Research Pharmacological Strategies Against Glucocorticoid-mediated Brain Damage During Chronic Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Current Organic Chemistry Cerebrovascular Damage as a Cause for Alzheimers Disease
Current Neurovascular Research Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer’s Disease Patients: How to Measure and Use It
Current Alzheimer Research The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s Disease
Current Alzheimer Research Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research The Blood-Brain Barrier in NeuroAIDS
Current HIV Research